Filing Details
- Accession Number:
- 0001261380-16-000110
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-07 19:47:07
- Reporting Period:
- 2016-09-02
- Filing Date:
- 2016-09-07
- Accepted Time:
- 2016-09-07 19:47:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1006045 | Iridex Corp | IRIX | Electromedical & Electrotherapeutic Apparatus (3845) | 770210467 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219636 | Ruediger Naumann-Etienne | 1212 Terra Bella Avenue Mountain View CA 94043 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-09-02 | 2,513 | $14.73 | 71,433 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-09-07 | 7,000 | $14.76 | 64,433 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 23,000 | Indirect | See Footnote |
Footnotes
- The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $14.22 to $14.8606 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $14.750 to $14.77365 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The Reporting Person is President of Naumann-Etienne Foundation and may be deemed to share voting and dispositive power of the shares held by his position.